The government panel, made up of doctors from the FDA, the Centers for Disease Control and Prevention, and the Department of Defense, recommended a trivalent flu vaccine for the 2025-26 season. The ...
The FDA is recommending that flu vaccines for the 2025-26 season be trivalent, protecting against two strains of influenza A and one of influenza B. “The FDA anticipates that there will be an ...
Background Because inactivated trivalent influenza vaccines (TIVs) contain 1 influenza B strain, whereas 2 lineages may co-circulate, B lineage mismatch is frequent. We assessed an inactivated ...
“The FDA anticipates that there will be an adequate and diverse supply of approved trivalent seasonal influenza vaccines” for the upcoming virus season, it said in a statement.There are several ways ...
“The FDA anticipates that there will be an adequate and diverse supply of approved trivalent seasonal influenza vaccines” for the upcoming virus season, it said in a statement.There are ...
Research acceleration: Replace traditional viral culture methods, shortening R&D timelines. IV. Sino Biological Unveils Comprehensive Influenza Research Reagents for 2025-2026 Vaccine Strains Sino ...